The efficacy and side effects of liposomal doxorubicin-based therapy and epirubicin-based therapy for breast cancer patients: a meta-analysis
Objective To conduct a meta-analysis to explore the specific efficacy and side effects of liposomal doxorubicin (LD) and epirubicin (E)-based therapies in breast cancer patients. Methods We searched 6 databases including PubMed, Embase, CNKI, Wanfang Data, Web of Science, and the Cochrane Library, a...
Saved in:
| Main Authors: | DENG Lang, XIONG Dayan, TIAN Jiashuo, DING Jinfeng, TANG Siyuan, LIU Wei |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Journal of Guangxi Medical University
2025-04-01
|
| Series: | Guangxi Yike Daxue xuebao |
| Subjects: | |
| Online Access: | https://journal.gxmu.edu.cn/article/doi/10.16190/j.cnki.45-1211/r.2025.02.016 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016-09-01) -
The supramolecular processing of liposomal doxorubicin hinders its therapeutic efficacy in cells
by: Annalisa Carretta, et al.
Published: (2024-09-01) -
Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
by: Boyan Atanasov, et al.
Published: (2022-06-01) -
Role of hesperidin/hesperetin against chemotherapy-induced cardiotoxicity: a systematic review of non-clinical studies
by: Sina Shaernejad, et al.
Published: (2025-05-01) -
Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
by: Jing-Jing Liu, et al.
Published: (2019-12-01)